Baxter Suspends Multiple-Dose Heparin Manufacturing Due To Excess Adverse Events
Firm avoids FDA recall; continues to manufacture single-dose vials of blood thinner.
Firm avoids FDA recall; continues to manufacture single-dose vials of blood thinner.